August 5, 2024 • 43min
Pattern Breakers
Daphne Koller is a polymath whose career has spanned academia, edtech entrepreneurship, and now biotech. As co-founder of Coursera, she helped revolutionize online education. Now, as founder and CEO of Insitro, she's applying machine learning to transform drug discovery. This episode explores Koller's journey from Stanford professor to startup founder, the challenges and triumphs of building Coursera, and her vision for using AI to accelerate medical breakthroughs.
Koller explains how Coursera emerged from Stanford's early experiments with massive open online courses (MOOCs):
"It became clear that was a way to have an incredible impact on the world in a very short amount of time. And so it was almost an opportunity I just couldn't let pass up," Koller recalls.
A key strategic decision was to work through university partnerships rather than going directly to individual professors:
Koller notes: "I had the intuition, which turned out to be true at the end, that a university professor at a top university at a Stanford or Princeton or whatever is going to want to teach a Stanford course, not a Coursera course."
Finding a viable business model while keeping content free was a major hurdle:
"We had a very deep commitment to the fact that the content should be free," Koller emphasizes. "That was part of the vision that caused me to want to put my research on hold and go and do this thing instead."
Coursera faced significant challenges from competitors and skeptics:
Koller credits authenticity and trust-building: "Gain trust of the people that can really help you at these really challenging moments, and do that by being authentic about who you are and what you're trying to achieve."
Koller shares impressive statistics and stories of Coursera's reach:
She recalls: "From a very early stage, at every all hands, we read a learner story... There was this one guy who was living in a car and didn't have a job and was able to get a job because of this. There was the woman in Bangladesh who was able to found a bakery that not only supported her and her friend, but ultimately seven other women because she learned business from Wharton online."
Koller reflects on what drives some academics to become entrepreneurs:
"The hard, the heavy lifting of making it robust - there's no incentives in place for that," Koller explains about academia. "So if your way of making impact requires you to have one or the other of those things, you're actually better off taking it out."
Koller discusses her post-Coursera career moves:
On starting Insitro, Koller says: "I realized that the approaches that were being employed in many ways hadn't changed for decades and that there were ways in which machine learning technology could be transformative to a process that is very expensive and very, very slow, and people are dying because they don't have medicines for grievous diseases."
Koller explains the challenge Insitro is tackling:
"What if we had a compass that tells us that each of the many places where we make a decision in this ten to twelve year journey, which is a path that is more likely to lead this to success, versus which are ones that are more likely to fail?" Koller asks. "Would we be able to make better decisions? And can machine learning help us make those decisions in a more data-informed way?"
Daphne Koller's journey from Stanford professor to co-founder of Coursera to her current role leading Insitro showcases the power of applying cutting-edge technology to solve major global challenges. Her experience building Coursera demonstrates both the immense potential and significant hurdles in disrupting traditional education models. Now, with Insitro, she's taking on an even more ambitious goal - using AI to revolutionize how we discover and develop life-saving drugs. Koller's career exemplifies how academics can transition to entrepreneurship to create real-world impact, while leveraging their deep expertise to tackle complex, interdisciplinary problems.